Does a Ureteral Stent with a Smaller Diameter Reduce Stent-Related Bladder Irritation? A Single-Blind, Randomized, Controlled, Multicenter Study

Kim, Bum Soo; Choi, Jae Young; Jung, Wonho

doi:10.1089/end.2019.0482

Cited by 20 publications

(20 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although it has been stated in some studies that ureteric stent use is redundant after uncomplicated ureteroscopic lithotripsy, in the present study, we routinely placed a ureteric stent as an insurance against possible complications such as development of hydronephrosis and renal colic [12]. The relationship between stent characteristics including size, material, softness, position, and loop completeness and SRS has been investigated with the aim of minimizing SRS, but to date the evidence has been conflicting [10,13,14]. The use of appropriately sized stents in patients could potentially decrease distal migration of stents and, in turn, reduce SRS [15].…”

Section: Discussionmentioning

confidence: 93%

A randomized trial investigating clinical outcomes and stent‐related symptoms after placement of a complete intra‐ureteric stent on a string versus conventional stent placement

et al. 2021

View full text Add to dashboard Cite

To compare stent-related symptoms (SRS) associated with conventional ureteric JJ stent (CUS) placement and SRS associated with placement of a modified complete intra-ureteric stent (CIUS) with extraction suture, designed to minimize SRS, using the validated Ureteral Stent Symptom Questionnaire (USSQ). Materials and MethodsWe randomized 124 patients who had undergone uncomplicated ureteroscopic lithotripsy into a CIUS and a CUS placement group. USSQ scores were evaluated on postoperative days 1 and 7 (just before stent removal) and 4 weeks after stent removal (control values). Pain scores on a visual analogue scale (VAS) after stent removal were also recorded. Subdomain analysis of all SRS and stent-related complications were also compared. ResultsNo significant intergroup differences were found in the domain scores for urinary symptoms (P = 0.74), pain (P = 0.32), general health (P = 0.27), work (P = 0.24), or additional problems (P = 0.29). However, a statistically significant difference was noted in VAS scores (P = 0.015). Analysis of subdomains of USSQ item scores showed the CIUS group had significantly better scores for urge incontinence (1.21 vs 1.00; P ≤ 0.001), discomfort on voiding (2.07 vs 1.50; P ≤ 0.001), difficulties with respect to light physical activity (1.131 vs 1.00; P ≤ 0.001), fatigue (1.84 vs 1.57; P = 0.002), feeling comfortable (3.68 vs 3.16; P = 0.003), need for extra help (1.96 vs 1.00; P ≤ 0.001), and change in duration of work (4.27 vs 1.86; P ≤ 0.001). However, the patients in the CIUS group were sexually inactive for the time during which the stent was indwelling (mean: 7.34 days). There was no difference in complication rates between the two groups. ConclusionThe use of a CIUS with strings after Ureteroscopy decreases SRS.

show abstract

Section: Discussionmentioning

confidence: 93%

A randomized trial investigating clinical outcomes and stent‐related symptoms after placement of a complete intra‐ureteric stent on a string versus conventional stent placement

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Kim et al performed a recent study comparing 5F to 6F ureteral stents and looked at quality of life (QOL) and patient-reported outcome measures (PROM). 13 They found no difference in QOL or PROM scores between these two different stent sizes.…”

Section: Ureteric Stentsmentioning

confidence: 95%

Practice-changing publications: Update in the management of urolithaisis

Powers¹,

Chew²

2021

CUAJ

View full text Add to dashboard Cite

show abstract

“…Other studies found that stent-related patient symptoms increase with the diameter of the stents. Therefore, smaller diameter stents should be preferred (8,9). Stent-related symptoms may be significantly mitigated with drug monotherapy or combination of beta-3 adrenergic receptor agonist, alpha-blockers and anticholinergic (10)(11)(12)(13)(14)(15)(16).…”

Section: Commentmentioning

confidence: 99%

Editorial Comment: The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial

Danilovic

2022

Int. braz j urol.

View full text Add to dashboard Cite

Does a Ureteral Stent with a Smaller Diameter Reduce Stent-Related Bladder Irritation? A Single-Blind, Randomized, Controlled, Multicenter Study

Cited by 20 publications

References 21 publications

A randomized trial investigating clinical outcomes and stent‐related symptoms after placement of a complete intra‐ureteric stent on a string versus conventional stent placement

A randomized trial investigating clinical outcomes and stent‐related symptoms after placement of a complete intra‐ureteric stent on a string versus conventional stent placement

Practice-changing publications: Update in the management of urolithaisis

Editorial Comment: The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial

Contact Info

Product

Resources

About